The PETITE study is evaluating two formulations of dolutegravir in newborn babies under 4 weeks of age – an oral film. In the ...

3TC: Lamivudine; ABC: Abacavir; DRV: Darunavir; DTG: Dolutegravir; EFV: Efavirenz; FTC: Emtricitabine; rtv: Ritonavir; TDF: Tenofovir. ↓: Decrease; ↑: Increase ...

San Francisco — The PETITE-DTG study evaluated dolutegravir (DTG) — a drug that revolutionized HIV treatment in adults and ...

A dissolvable oral dispersible film of dolutegravir could transform treatment ANALYSIS | MELODY CHIRONDA | In the fight ...

Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...

Kenya is among six African countries at risk of running out of HIV drugs following the recent decision by the US government ...

Dolutegravir/lamivudine showed efficacy in achieving viral suppression in treatment-naive adolescents with HIV after 48 weeks. The study included 32 adolescents, with ...

Cancellation letters, which end millions of rands of South African universities’ US-government funded HIV and TB research ...

【药物相互作用】 （1）代谢诱导剂药物可能减低dolutegravir的血浆浓度。 （2）应在服用含阳离子抗酸药或泻药，硫糖铝，口服铁补充剂，口服钙补充剂，或缓冲药物前2小时或后6小时服用TIVICAY。 【安全与疗效】 ING111762（SAILING）是一个为期48周的3期随机双盲对照 ...

Dolutegravir is one of the most effective and safest HIV medicines and is used by millions of adults and adolescents living with HIV in over 100 countries. But there’s no specific drug formulation for ...